Who Buys Itraconazole from India — 629 Importers Behind a $27.4M Market
India's itraconazole import market is served by 629 active buyers who collectively imported $27.4M across 2,727 shipments. NEOETHICALS, S.A, (NICARAGUA) leads with a 7.5% market share, followed by NOVAMED FABRICACAO DE PRODUTOS and AMNEAL PHARMACEUTICALS, LLC (KY). The top 5 buyers together control 25.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Itraconazole Importers — Ranked by Import Value
NEOETHICALS, S.A, (NICARAGUA) is the leading itraconazole importer from India, holding a 7.5% share of the $27.4M market across 2,727 shipments from 629 buyers. The top 5 buyers — NEOETHICALS, S.A, (NICARAGUA), NOVAMED FABRICACAO DE PRODUTOS (BRAZIL), AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES), ASCEND LABORATORIES,LLC (UNITED STATES), NEOETHICALS CIA LTDA (ECUADOR) — collectively control 25.3% of total import value.
Top Itraconazole Buyers & Importers
Ranked by import value · 629 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | NEOETHICALS, S.A,NICARAGUA ITRACONAZOLE CAPSULES 100MGITRACOREN | $2.1M | 5 | 7.5% |
| 2 | NOVAMED FABRICACAO DE PRODUTOSBRAZIL ITRACONAZOLE IR PELLETS 22%ITRACONAZOLE IR PELLETS 22% W/WITRACONAZOLE IR PELLETS 22%KGS | $1.6M | 5 | 5.8% |
| 3 | AMNEAL PHARMACEUTICALS, LLC (KY)UNITED STATES ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $1.4M | 5 | 5.1% |
| 4 | ASCEND LABORATORIES,LLCUNITED STATES ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $998.1K | 5 | 3.6% |
| 5 | NEOETHICALS CIA LTDAECUADOR ITRACONAZOLE CAPSULES 100MGITRACONAZOLE PELLETS 22% W/WITRACOREN | $885.6K | 5 | 3.2% |
| 6 | AMNEAL PHARMACEUTICALS LLC KYUNITED STATES ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $707.1K | 5 | 2.6% |
| 7 | ACINO PHARMA AGSWITZERLAND PH.DRU.& MED.: ITRACONAZOLE CAPSULES 100 | $676.1K | 5 | 2.5% |
| 8 | MICRO HEALTHCARE (PRIVATE) LIMITEDSRI LANKA ITRACON ITRACONAZOLE CAPSULES 100MG 5X10SITRACON CAPSULES [ITRACON [ | $670.6K | 5 | 2.5% |
| 9 | MICRO HEALTHCARE PRIVATE LIMITEDSRI LANKA ITRACON ITRACONAZOLE CAPSULES 100MG 5X10SITRACON CAPSULES [ITRACON [ | $618.8K | 5 | 2.3% |
| 10 | NOVAMED FABRICACAO DE PRODUCTOSBRAZIL ITRACONAZOLE IR PELLETS 22%ITRACONAZOLE IR PELLETS 22% W/WITRACONAZOLE IR PELLETS 22%KGS | $587.0K | 5 | 2.1% |
| 11 | CAMBER PHARMACEUTICALS INCUNITED STATES ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $545.4K | 5 | 2.0% |
| 12 | LIFE PHARMA FZEUNITED ARAB EMIRATES ITRACONAZOLE 100MG HARD GELATINE CAPSULES | $524.2K | 5 | 1.9% |
| 13 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES | $451.3K | 5 | 1.6% |
| 14 | J. KNIPPER & COMPANYUNITED STATES ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $428.8K | 5 | 1.6% |
| 15 | ASCEND LABORATORIES LLCUNITED STATES ITRACONAZOLE SOLUTIONITRACONAZOLE 10MG/ML SOLUTIONITRACONAZOLE 10MG ML SOLUTION | $412.3K | 5 | 1.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Itraconazole — and from which countries?
Flow of Itraconazole exports from India: each country's share and the named importers behind the numbers
Itraconazole — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $9.2M through 85 shipments. This represents a market share of 33.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• AMNEAL PHARMACEUTICALS, LLC (KY) - $1.4M (15.3% of country's total business)
• ASCEND LABORATORIES,LLC - $998.1K (10.9% of country's total business)
• AMNEAL PHARMACEUTICALS LLC KY - $707.1K (7.7% of country's total business)
• CAMBER PHARMACEUTICALS INC - $545.4K (5.9% of country's total business)
• NORTHSTAR DISTRIBUTION CENTER 8912 - $451.3K (4.9% of country's total business)
• Rest of United States's importers - $5.1M (55.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $107.9K, indicating premium pricing strategy compared to the market average of $10.0K.
United States is a key market for Itraconazole imports, representing 33.5% of total trade value.
2Brazil
Brazil emerges as the second largest importing country, achieving a total trade value of $2.4M through 23 shipments. This represents a market share of 8.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• NOVAMED FABRICACAO DE PRODUTOS - $1.6M (64.8% of country's total business)
• NOVAMED FABRICACAO DE PRODUCTOS - $587.0K (24.2% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $105.7K, indicating premium pricing strategy compared to the market average of $10.0K.
Brazil is a key market for Itraconazole imports, representing 8.9% of total trade value.
3Nicaragua
Nicaragua emerges as the third largest importing country, achieving a total trade value of $2.1M through 3 shipments. This represents a market share of 7.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nicaragua has a diverse importer base, with their top importers including:
• NEOETHICALS, S.A, - $2.1M (100.0% of country's total business)
Key Insight: Nicaragua demonstrates strong market positioning with an average shipment value of $686.4K, indicating premium pricing strategy compared to the market average of $10.0K.
Nicaragua is a key market for Itraconazole imports, representing 7.5% of total trade value.
4Sri Lanka
Sri Lanka emerges as the fourth largest importing country, achieving a total trade value of $1.7M through 18 shipments. This represents a market share of 6.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• MICRO HEALTHCARE (PRIVATE) LIMITED - $670.6K (38.9% of country's total business)
• MICRO HEALTHCARE PRIVATE LIMITED - $618.8K (35.9% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $95.8K, indicating premium pricing strategy compared to the market average of $10.0K.
Sri Lanka is a key market for Itraconazole imports, representing 6.3% of total trade value.
5Switzerland
Switzerland emerges as the fifth largest importing country, achieving a total trade value of $1.4M through 20 shipments. This represents a market share of 5.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Switzerland has a diverse importer base, with their top importers including:
• ACINO PHARMA AG - $676.1K (48.2% of country's total business)
Key Insight: Switzerland demonstrates strong market positioning with an average shipment value of $70.1K, indicating premium pricing strategy compared to the market average of $10.0K.
Switzerland is a key market for Itraconazole imports, representing 5.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Itraconazole buyer market intelligence
1Buyer Segment Analysis
The importers of Itraconazole from India can be categorized into several key segments:
1. Pharmaceutical Distributors: Entities like NEOETHICALS, S.A. (Nicaragua) and NOVAMED FABRICACAO DE PRODUTOS (Brazil) fall into this category. These distributors procure large quantities of Itraconazole to supply to various healthcare providers, pharmacies, and hospitals within their respective countries. Their purchasing patterns are characterized by bulk orders to meet the consistent demand for antifungal medications.
2. Contract Manufacturers: Companies such as AMNEAL PHARMACEUTICALS, LLC (United States) and ASCEND LABORATORIES, LLC (United States) represent this segment. They import Itraconazole as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is typically aligned with production schedules and market demand forecasts, leading to periodic, substantial orders.
3. Re-exporters: Entities like ACINO PHARMA AG (Switzerland) may act as re-exporters, importing Itraconazole for distribution to other markets. This segment's buying behavior is influenced by global demand trends and regulatory approvals in target markets, resulting in variable order sizes and frequencies.
4. Healthcare Providers: Organizations such as MICRO HEALTHCARE (PRIVATE) LIMITED (Sri Lanka) import Itraconazole directly for use within their healthcare facilities. Their purchasing patterns are driven by patient needs and treatment protocols, leading to regular, moderate-sized orders.
The repeat buyer rate of 48.5% indicates a stable demand across these segments, with distributors and contract manufacturers showing higher repeat purchase tendencies due to ongoing market needs and production requirements.
Country-Specific Import Regulations
TransData Nexus Itraconazole buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Itraconazole in the top importing countries is crucial for market entry and compliance:
1. United States:
2. Brazil:
3. Nicaragua:
4. Sri Lanka:
5. Switzerland:
Demand Drivers & Market Opportunity
TransData Nexus Itraconazole buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Itraconazole in importing countries is influenced by several key factors:
1. Disease Prevalence: Itraconazole is essential in treating systemic fungal infections such as histoplasmosis, aspergillosis, and blastomycosis. The prevalence of these infections, particularly in immunocompromised populations, drives consistent demand.
2. Inclusion in Essential Medicines Lists: Itraconazole's inclusion in the WHO Model List of Essential Medicines underscores its importance in public health. This designation encourages countries to incorporate it into their national essential medicines lists, facilitating procurement and distribution.
3. Government Healthcare Programs: Many countries have implemented programs aimed at improving access to essential medicines. For instance, the WHO's Health Technologies and Pharmaceuticals Programme has been instrumental in guiding countries to update their essential medicines lists and improve access to critical medications. (who.int)
4. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased availability and affordability of essential medicines, including antifungals like Itraconazole.
5. Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring a steady demand for Itraconazole.
With 629 buyers across 123 countries, the global market for Itraconazole demonstrates significant breadth. The combination of disease prevalence, inclusion in essential medicines lists, and supportive healthcare policies continues to drive demand, presenting substantial market opportunities for suppliers.
Common Questions — Itraconazole Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest itraconazole buyer importing from India?
Based on import volume and value, NEOETHICALS, S.A, (NICARAGUA) leads with $2.1M in imports and a 7.5% market share — the highest of any single itraconazole importer. NOVAMED FABRICACAO DE PRODUTOS (BRAZIL) and AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES) are the next largest buyers.
QHow many companies buy itraconazole from India?
There are 629 active itraconazole buyers importing from India, with a combined market of $27.4M across 2,727 shipments to 123 countries. The top 5 buyers hold 25.3% of total import value, while the remaining 624 buyers handle the other 74.7%.
QWhich countries import the most itraconazole from India?
The top importing countries for itraconazole from India are United States (33.5%), Brazil (8.9%), Nicaragua (7.5%), Sri Lanka (6.3%), Switzerland (5.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of itraconazole, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for itraconazole from India?
The average import transaction value for itraconazole from India is $10.0K, with an average unit price of $9.47 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Itraconazole buyer market intelligence
1Buyer Segment Analysis
The importers of Itraconazole from India can be categorized into several key segments:
1. Pharmaceutical Distributors: Entities like NEOETHICALS, S.A. (Nicaragua) and NOVAMED FABRICACAO DE PRODUTOS (Brazil) fall into this category. These distributors procure large quantities of Itraconazole to supply to various healthcare providers, pharmacies, and hospitals within their respective countries. Their purchasing patterns are characterized by bulk orders to meet the consistent demand for antifungal medications.
2. Contract Manufacturers: Companies such as AMNEAL PHARMACEUTICALS, LLC (United States) and ASCEND LABORATORIES, LLC (United States) represent this segment. They import Itraconazole as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is typically aligned with production schedules and market demand forecasts, leading to periodic, substantial orders.
3. Re-exporters: Entities like ACINO PHARMA AG (Switzerland) may act as re-exporters, importing Itraconazole for distribution to other markets. This segment's buying behavior is influenced by global demand trends and regulatory approvals in target markets, resulting in variable order sizes and frequencies.
4. Healthcare Providers: Organizations such as MICRO HEALTHCARE (PRIVATE) LIMITED (Sri Lanka) import Itraconazole directly for use within their healthcare facilities. Their purchasing patterns are driven by patient needs and treatment protocols, leading to regular, moderate-sized orders.
The repeat buyer rate of 48.5% indicates a stable demand across these segments, with distributors and contract manufacturers showing higher repeat purchase tendencies due to ongoing market needs and production requirements.
Country-Specific Import Regulations
TransData Nexus Itraconazole buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Itraconazole in the top importing countries is crucial for market entry and compliance:
1. United States:
2. Brazil:
3. Nicaragua:
4. Sri Lanka:
5. Switzerland:
Demand Drivers & Market Opportunity
TransData Nexus Itraconazole buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Itraconazole in importing countries is influenced by several key factors:
1. Disease Prevalence: Itraconazole is essential in treating systemic fungal infections such as histoplasmosis, aspergillosis, and blastomycosis. The prevalence of these infections, particularly in immunocompromised populations, drives consistent demand.
2. Inclusion in Essential Medicines Lists: Itraconazole's inclusion in the WHO Model List of Essential Medicines underscores its importance in public health. This designation encourages countries to incorporate it into their national essential medicines lists, facilitating procurement and distribution.
3. Government Healthcare Programs: Many countries have implemented programs aimed at improving access to essential medicines. For instance, the WHO's Health Technologies and Pharmaceuticals Programme has been instrumental in guiding countries to update their essential medicines lists and improve access to critical medications. (who.int)
4. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased availability and affordability of essential medicines, including antifungals like Itraconazole.
5. Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring a steady demand for Itraconazole.
With 629 buyers across 123 countries, the global market for Itraconazole demonstrates significant breadth. The combination of disease prevalence, inclusion in essential medicines lists, and supportive healthcare policies continues to drive demand, presenting substantial market opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 629 global importers of Itraconazole identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,727 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 123 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,727 Verified Shipments
629 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists